/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

B

Björn Stollenwerk

Health Economics and Outcomes Research (United Kingdom)(GB)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

102

Papers

1.9K

Citations

23

h-index

36

i10-index

Björn Stollenwerk is an academic researcher from Health Economics and Outcomes Research (United Kingdom). The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Lung Cancer Treatments and Mutations & Lipoproteins and Cardiovascular Health. The author has an h-index of 23, co-authored 87 publications.

ORCID: 0000-0002-3189-409X

Research Topics

Health Systems, Economic Evaluations, Quality of Life Lung Cancer Treatments and Mutations Lipoproteins and Cardiovascular Health Economic and Financial Impacts of Cancer Health and Medical Studies

Papers by this author

works

Waiting times for elective treatments according to insurance status: A randomized empirical study in Germany

2008 · International Journal for Equity in Health · 179 citations

https://doi.org/10.1186/1475-9276-7-1

Markus Lüngen Björn Stollenwerk Philipp Messner Karl W. Lauterbach

Effects of a nurse-based case management compared to usual care among aged patients with myocardial infarction: results from the randomized controlled KORINNA study

2013 · BMC Geriatrics · 52 citations

https://doi.org/10.1186/1471-2318-13-115

Christa Meisinger Björn Stollenwerk Inge Kirchberger Hildegard Seidl

The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer

2014 · BMC Health Services Research · 37 citations

https://doi.org/10.1186/1472-6963-14-163

Florian Koerber Raphaela Waidelich Björn Stollenwerk Wolf Rogowski

Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada

2022 · Archives of Osteoporosis · 13 citations

https://doi.org/10.1007/s11657-022-01106-9

Ron Goeree Natasha Burke Manon Jobin Jacques P. Brown

Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan

2021 · Archives of Osteoporosis · 9 citations

https://doi.org/10.1007/s11657-021-01020-6

Ben Johnson Edward Chia‐Cheng Lai Huang‐Tz Ou Hong Li

Real-World Evaluation of Treatment Patterns, Healthcare Costs, and Healthcare Resource Utilization Among Patients with Non-small Cell Lung Cancer in the US Receiving Sotorasib

2024 · Advances in Therapy · 5 citations

https://doi.org/10.1007/s12325-024-03020-7

Ihtisham Sultan David Waterhouse Divyan Chopra Alexander Lonshteyn

Research topics

topics

Health Systems, Economic Evaluations, Quality of Life

Lung Cancer Treatments and Mutations

Lipoproteins and Cardiovascular Health

Economic and Financial Impacts of Cancer

Health and Medical Studies

Chat about Author

Papers

Chat

Click to start Chat